{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:28:59Z","timestamp":1740126539164,"version":"3.37.3"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"43","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,14]]},"DOI":"10.1093\/eurheartj\/ehaa418","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T19:17:25Z","timestamp":1588792645000},"page":"4188-4190","source":"Crossref","is-referenced-by-count":4,"title":["Marfan sartan saga, episode X"],"prefix":"10.1093","volume":"41","author":[{"given":"Guillaume","family":"Jondeau","sequence":"first","affiliation":[{"name":"Centre national de r\u00e9f\u00e9rence pour le syndrome de Marfan et apparent\u00e9s, VASCERN HTAD European Reference Center, AP-HP, H\u00f4pital Bichat , Paris, France"},{"name":"Service de Cardiologie, AP-HP, H\u00f4pital Bichat , Paris, France"},{"name":"INSERM U1148, H\u00f4pital Bichat , Paris, France"},{"name":"Universit\u00e9 de Paris , Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Milleron","sequence":"additional","affiliation":[{"name":"Centre national de r\u00e9f\u00e9rence pour le syndrome de Marfan et apparent\u00e9s, VASCERN HTAD European Reference Center, AP-HP, H\u00f4pital Bichat , Paris, France"},{"name":"Service de Cardiologie, AP-HP, H\u00f4pital Bichat , Paris, France"},{"name":"INSERM U1148, H\u00f4pital Bichat , Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0371-7539","authenticated-orcid":false,"given":"Catherine","family":"Boileau","sequence":"additional","affiliation":[{"name":"Centre national de r\u00e9f\u00e9rence pour le syndrome de Marfan et apparent\u00e9s, VASCERN HTAD European Reference Center, AP-HP, H\u00f4pital Bichat , Paris, France"},{"name":"INSERM U1148, H\u00f4pital Bichat , Paris, France"},{"name":"Universit\u00e9 de Paris , Paris, France"},{"name":"D\u00e9partement de G\u00e9n\u00e9tique, AP-HP, H\u00f4pital Bichat , Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"2022102508345192800_ehaa418-B1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.5603\/KP.2014.0225","article-title":"[2014 ESC Guidelines on the diagnosis and treatment of aortic diseases]","volume":"72","author":"Erbel","year":"2014","journal-title":"Kardiol Pol"},{"key":"2022102508345192800_ehaa418-B2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"2022102508345192800_ehaa418-B3","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","article-title":"Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial","volume":"34","author":"Groenink","year":"2013","journal-title":"Eur Heart J"},{"key":"2022102508345192800_ehaa418-B4","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan\u2019s syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N Engl J Med"},{"key":"2022102508345192800_ehaa418-B5","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","article-title":"Marfan Sartan: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Milleron","year":"2015","journal-title":"Eur Heart J"},{"key":"2022102508345192800_ehaa418-B6","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/eurheartj\/ehv575","article-title":"Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial","volume":"37","author":"Forteza","year":"2016","journal-title":"Eur Heart J"},{"key":"2022102508345192800_ehaa418-B7","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0140-6736(19)32518-8","article-title":"AIMS Investigators. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial","volume":"394","author":"Mullen","year":"2020","journal-title":"Lancet"},{"key":"2022102508345192800_ehaa418-B8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/heartjnl-2013-304920","article-title":"Aortic dilatation patterns and rates in adults with bicuspid aortic valves: a comparative study with Marfan syndrome and degenerative aortopathy","volume":"100","author":"Detaint","year":"2014","journal-title":"Heart"},{"key":"2022102508345192800_ehaa418-B9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.echo.2014.11.015","article-title":"Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging: endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance","volume":"28","author":"Goldstein","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2022102508345192800_ehaa418-B10","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa377","volume":"41","author":"van Andel","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102508345192800_ehaa418-B11","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.jacc.2018.07.052","article-title":"Losartan versus atenolol for prevention of aortic dilation in patients with Marfan syndrome","volume":"72","author":"Teixido-Tura","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102508345192800_ehaa418-B12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/CIRCGENETICS.116.001485","article-title":"International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: Results of the MAC (Montalcino Aortic Consortium)","volume":"9","author":"Jondeau","year":"2016","journal-title":"Circulation Cardiovascular Genetics"},{"key":"2022102508345192800_ehaa418-B13","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(05)67760-4","article-title":"CHARM investigators. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial","volume":"366","author":"Granger","year":"2005","journal-title":"Lancet"},{"key":"2022102508345192800_ehaa418-B14","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1161\/CIRCULATIONAHA.109.887042","article-title":"Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders","volume":"120","author":"Attias","year":"2009","journal-title":"Circulation"},{"key":"2022102508345192800_ehaa418-B15","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1093\/eurheartj\/ehv739","article-title":"Genotype impacts survival in Marfan syndrome","volume":"37","author":"Franken","year":"2016","journal-title":"Eur Heart J"},{"key":"2022102508345192800_ehaa418-B16","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1136\/heartjnl-2016-310631","article-title":"Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome","volume":"103","author":"Franken","year":"2017","journal-title":"Heart"},{"key":"2022102508345192800_ehaa418-B17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/HCO.0000000000000218","article-title":"Arterial tortuosity in genetic arteriopathies","volume":"30","author":"Morris","year":"2015","journal-title":"Curr Opin Cardiol"},{"key":"2022102508345192800_ehaa418-B18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2015.05.072","article-title":"Increased aortic tortuosity indicates a more severe aortic phenotype in adults with Marfan syndrome","volume":"194","author":"Franken","year":"2015","journal-title":"Int J Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/43\/4188\/46617277\/ehaa418.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/43\/4188\/46617277\/ehaa418.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T08:50:11Z","timestamp":1666687811000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/41\/43\/4188\/5865495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":18,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2020,7,1]]},"published-print":{"date-parts":[[2020,11,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaa418","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"type":"print","value":"0195-668X"},{"type":"electronic","value":"1522-9645"}],"subject":[],"published-other":{"date-parts":[[2020,11,14]]},"published":{"date-parts":[[2020,7,1]]}}}